131 related articles for article (PubMed ID: 36283873)
1. The effect of C-reactive protein/albumin ratio on overall survival in patients with oral squamous cell carcinoma: A meta-analysis.
Lu H; Huang MN; Li CY; Tang SJ
Asian J Surg; 2023 Apr; 46(4):1728-1730. PubMed ID: 36283873
[No Abstract] [Full Text] [Related]
2. Preoperative C-reactive protein to albumin ratio and oral health in oral squamous cell carcinoma patients.
Keinänen A; Uittamo J; Marinescu-Gava M; Kainulainen S; Snäll J
BMC Oral Health; 2021 Mar; 21(1):132. PubMed ID: 33740951
[TBL] [Abstract][Full Text] [Related]
3. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
4. Commentary on 'Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis' (He et al., (2020) Archives of Oral Biology, 114, 104717).
Peña-Cardelles JF; Moro-Rodríguez JE; Cebrián-Carretero JL; Pozo-Kreilinger JJ
Arch Oral Biol; 2021 Dec; 132():105274. PubMed ID: 34678606
[No Abstract] [Full Text] [Related]
5. Oral squamous cell carcinoma in the young patient: an emerging unique cohort of patients.
Kolokythas A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):617. PubMed ID: 35431174
[No Abstract] [Full Text] [Related]
6. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the nodal yield in oral squamous cell carcinoma: a systematic review and meta-analysis.
Li J; Xu Y; Zhang J; Wang S; Wang X; Guo H; Miao G
Expert Rev Anticancer Ther; 2023 Mar; 23(3):339-345. PubMed ID: 36645663
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Oral and Oropharyngeal Squamous Cell Carcinoma Related to Healthcare Coverage: A Retrospective Cohort Study in Brazil.
Dantas TS; de Sousa ASA; Sales TOP; deOliveira Filho OV; de Barros Silva PG; Alves APNN; Mota MRL; Sousa FB
Cancer Invest; 2022 Sep; 40(8):680-692. PubMed ID: 35731734
[TBL] [Abstract][Full Text] [Related]
9. Impact of histological tumor grade on the behavior and prognosis of squamous cell carcinoma of the oral cavity.
Cariati P; Martinez Sahuquillo Rico A; Ferrari L; Pampin Ozan D; Gonzalez Corcóles C; Arroyo Rodriguez S; Ferrari S; Lara IM
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e808-e813. PubMed ID: 35811024
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of Beta-2 Adrenergic Receptor in oral squamous cell carcinoma.
Krishna A; Singh S; Kumar V
Oral Oncol; 2022 Feb; 125():105720. PubMed ID: 35065454
[No Abstract] [Full Text] [Related]
11. Elective neck dissection may not necessarily reduce recurrence and improve survival in all cases of early stage (CT1/2 N0 M0) oral squamous cell carcinoma.
Chuang SK; Lee KC
J Evid Based Dent Pract; 2021 Jun; 21(2):101573. PubMed ID: 34391558
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma.
Farhan-Alanie OM; McMahon J; McMillan DC
Br J Oral Maxillofac Surg; 2015 Feb; 53(2):126-31. PubMed ID: 25440150
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma - "Need for incorporation of sub classification of pT4b lesions".
Amith K P ; V Lal R; Lakshmi Pandey R; Thakur S
Oral Oncol; 2022 Sep; 132():106014. PubMed ID: 35835054
[No Abstract] [Full Text] [Related]
14. Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.
Tanoue K; Tamura S; Kusaba H; Shinohara Y; Ito M; Tsuchihashi K; Shirakawa T; Otsuka T; Ohmura H; Isobe T; Ariyama H; Koreishi S; Matsushita Y; Shimokawa H; Tanaka R; Mitsugi K; Akashi K; Baba E
Sci Rep; 2021 Feb; 11(1):2741. PubMed ID: 33531609
[TBL] [Abstract][Full Text] [Related]
15. Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma.
Li G; Da M; Zhang W; Wu H; Ye J; Chen J; Ma L; Gu N; Wu Y; Song X
J Oral Pathol Med; 2016 Mar; 45(3):167-72. PubMed ID: 26189546
[TBL] [Abstract][Full Text] [Related]
16. Evaluated expression of CELSR3 in oral squamous cell carcinoma is associated with perineural invasion and poor prognosis.
Zheng K; Lan T; Li GP; Huang L; Chen YP; Su BH; Zhang S; Zheng DL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 May; 133(5):564-573. PubMed ID: 35165064
[TBL] [Abstract][Full Text] [Related]
17. [Oral cavity squamous cell carcinoma also occurs in children].
Prinsze KJ; van Noesel MM; Smeele LE
Ned Tijdschr Tandheelkd; 2022 Sep; 129(10):385-389. PubMed ID: 36074644
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.
Chen Y; Cong R; Ji C; Ruan W
Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cathepsin L and its inhibitor headpin in oral squamous cell carcinoma.
Nakashima T; Yasumatsu R; Masuda M; Clayman GL; Komune S
J Laryngol Otol; 2012 Nov; 126(11):1134-7. PubMed ID: 22963824
[TBL] [Abstract][Full Text] [Related]
20. The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literature.
Quinton BA; Cabrera CI; Tamaki A; Li S; Fowler N; Rezaee R; Lavertu P; Teknos T; Pan Q; Thuener J
Am J Otolaryngol; 2022; 43(4):103511. PubMed ID: 35609426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
